Trials / Completed
CompletedNCT03530280
Effect of Pregabalin or Adductor Canal Block on Postoperative Analgesia
Effect of Pregabalin or Adductor Canal Block on Postoperative Analgesia After Arthroscopic Anterior Cruciate Ligament Reconstruction (ACL)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 51 (actual)
- Sponsor
- Ankara Diskapi Training and Research Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
arthroscopically Anterior Cruciate Ligament Reconstruction (ACL) under spinal anesthesia were included in this study.
Detailed description
Patients who American Society of Anesthesiologists (ASA) classification I to II scheduled to undergo arthroscopically assisted ACL reconstructions under spinal anesthesia are included in this study. The first group is administered 150 mg oral pregabalin 1 hour before surgery and the postoperative sham block was performed with an ultrasound probe. The second group is the control group; patients in this group are administered a placebo capsule 1 hour before surgery and sham block was performed with an ultrasound probe.The third group is administered a placebo capsule 1 hour before surgery and postoperative adductor canal block is performed. All patients will be received postoperative a tramadol i.v. patient control analgesia device. At the end of 24 hours, the total amount of tramadol consumed by the patient will be recorded from the patient control analgesia. NRS score, white fast track, satisfaction will be questioned.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pregabalin (lyrica) | preoperative pregabalin and the postoperative sham block will perform. |
| DRUG | Placebo oral tablet | The preoperative placebo oral tablet and the postoperative sham block will perform. |
| DRUG | adductor canal block including bupivacaine | The preoperative placebo oral tablet and adductor channel block including 10 mL of 0.25% bupivacaine with 5 μg/mL epinephrine |
Timeline
- Start date
- 2018-06-01
- Primary completion
- 2018-10-01
- Completion
- 2018-12-01
- First posted
- 2018-05-21
- Last updated
- 2019-10-18
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT03530280. Inclusion in this directory is not an endorsement.